Asztma: vizsgálatok itt: Kína
78 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Where
- Beijing, Changchun, Hohhot, Lanzhou, Nanjing, Shanghai, Shenyang, Shenzhen, Tianjin, Wuxi, Zhanjiang, Zhongshan
- Életkor
- 5 év to 11 év
- People
- 231 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06023589 - 3. fázisTaking peopleEvaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Where
- Beijing, Bengbu, Chengdu, Chongqing, Hohhot, Mianyang, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Taizhou, Tianjin, Wuhan, Yanji, Yantai, Zhongshan
- Életkor
- 12 év to 17 év
- People
- 440 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307665 - No phaseTaking peopleA Multicentre, Single Arm, Non-interventional, Real-world Study to Assess Demographic Characteristics and Patient Reported Outcomes in Patients With Severe Eosinophilic Asthma Treated With Benralizumab in China
- Where
- Anning, Beijing, Binzhou, Changzhou, Fenyang, Guangdong, Guangzhou, Hangzhou, Hefei, Huzhou, Jiaxing, Jinan, Jinhua, Jining, Jiyuan, Kunshan, Linyi, Mianyang, Nanbu, Nanchang, Nanjing, Ningbo, Shanghai, Shanxi, Shenzhen, Shijiazhuang, Suining, Taiyuan, Weifang, Wuhan, Wuxi, Xiamen, Xi'an, Zhangjiagang, Zhengzhou, Zhenjiang
- Életkor
- 12 év and over
- People
- 700
- Run by
- AstraZeneca
See details and how to joinNCT06862206 - 2. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Where
- Baotou, Beijing, Changchun, Chengdu, Guangzhou, Hangzhou, Hohhot, Najing, Nanchang, Nanjing, Shanghai, Taizhou, Xi'an, Xuzhou
- Életkor
- 18 év to 75 év
- People
- 252 worldwide
- Run by
- Pfizer
See details and how to joinNCT06977581 · EU 2024-517866-40-00 - 2. fázisTaking peopleA Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Where
- Baotou, Beijing, Chengdu, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai, Shenzhen, Shijiazhuang, Tianjin, Wenzhou, Wuhan
- Életkor
- 18 év to 75 év
- People
- 531 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07219173 - 3. fázisTaking peoplePhase 3b Study in Patients With Severe Asthma Treated With Tezepelumab
- Where
- Beijing, Binzhou, Changsha, Chengdu, Chongqing, Deyang, Fuzhou, Guangzhou, Guiyang, Hangzhou, Hefei, Hohhot, Jiangmen, Jinan, Jining, Kunming, Leshan, Linyi, Luzhou, Meizhou, Mianyang, Nanchang, Nanjing, Nanning, Ningbo, Quanzhou, Shanghai, Shantou, Shenyang, Shenzhen, Shijiazhuang, Suining Shi, Suzhou, Taiyuan, Tianjin, Weifang, Wenzhou, Wuhan, Wuxi, Xi'an, Zhangzhou, Zhanjiang, Zhengzhou, Zhongshan
- Életkor
- 12 év to 80 év
- People
- 400
- Run by
- AstraZeneca
See details and how to joinNCT07363642 - 2. fázisTaking peopleA Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
- Where
- Beijing, Changzhou, Ningbo, Taiyuan
- Életkor
- 18 év to 85 év
- People
- 440 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07746687 · EU 2026-526262-24-00 - No phaseTaking peopleConstruction and Validation of an Impulse Oscillometry (IOS)-Based Platform for Screening, Diagnosis, and Management of Chronic Airway Diseases
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 2800
- Run by
- Beijing Chao Yang Hospital
See details and how to joinNCT07910409 - 2. fázisTaking peopleDose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Where
- Baotou, Changchun, Chengdu, Chongqing, Guangzhou, Haikou, Hefei, Hohhot, Huizhou, Qingdao, Shanghai, Shenzhen, Wenzhou, Xuzhou
- Életkor
- 18 év to 75 év
- People
- 540 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06932263 · EU 2024-519116-14-00 - 1/2. fázisTaking peopleA Study of HB0056 in Adult Participants With Moderate to Severe Asthma
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 160
- Run by
- Shanghai Huaota Biopharmaceutical Co., Ltd.
See details and how to joinNCT07899996 - No phaseTaking peopleExplore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis
- Where
- Beijing, Cangzhou, Changsha, Chengdu, Chongqing, Guangzhou, Kunming, Quanzhou, Shanghai, Suzhou, Taiyuan, Tianjin, Ürümqi, Wuhan, Xi'an, Yangzhou, Zhengzhou, Zhuhai
- Életkor
- 18 év to 75 év
- People
- 500
- Run by
- AstraZeneca
See details and how to joinNCT07516184 - No phaseTaking peopleImpact of GDMT in Uncontrolled Asthma Patients Receiving MHD Inhaled Corticosteroids + Long-acting β2 Agonist
- Where
- Chengdu, Chifeng, Dongyang, Hefei, Hengyang, Heze, Jiaxing, Langfang, Meizhou, Quanzhou, Shanghai, Shiyan, Tai’an, Ürümqi, Xi'an, Yantai, Yongzhou, Yunnan, Zhanjiang
- People
- 540
- Run by
- AstraZeneca
See details and how to joinNCT07718724 - No phaseNot yet taking people in KínaReal-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Qianfoshan Hospital
See details and how to joinNCT07828327 - 3. fázisTaking peopleA Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
- Where
- Baotou, Beijing, Changchun, Changsha, Chengdu, Chizhou, Chongqing, Dazhou, Deyang, Ganzhou, Guangyuan, Guangzhou, Haikou, Hangzhou, Hefei, Heifei, Hohhot, Huizhou, Jinan, Jinhua, Jining, Kunming, Lanzhou, Linhai, Luoyang, Luzhou, Mianyang, Nanchang, Nanchong, Nanjing, Nantong, Ningbo, Panjin, Panzhihua, Pingxiang, Qingdao, Rui’an, Sanya, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Suining, Taiyuan, Tianjin, Ürümqi, Wenzhou, Wuhan, Wuhu, Xiamen, Xi'an, Xintai, Xinxiang, Xuzhou, Yangzhou, Yibin, Yinchuan, Yueyang, Yuhuan, Zhangzhou, Zhengzhou, Zhuhai, Zhuji, Zibo, Zigong, Zunyi
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06471257 - 2. fázisCsak meghívásosLong-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
- Where
- Beijing, Changchun, Changsha, Chengde, Guangzhou, Guiyang, Hefei, Hohhot, Lanzhou, Nanchang, Pingxiang, Shanghai, Shenyang, Taiyuan, Tianjin, Wenzhou, Wuhan, Xuzhou, Yangzhou, Zhanjiang
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00 - No phaseTaking peopleT2AIR: Real-World Efficacy and Safety of Biologics Targeting Type 2 Inflammation in Asthma and COPD
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 538
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07823842 - No phaseNot yet taking people in KínaChildhood Infection and Immunity Longitudinal Cohort
- Where
- Dongyang, Yiwu
- Életkor
- 0 nap to 7 év
- People
- 1200
- Run by
- Zhejiang Provincial Center for Disease Control and Prevention
See details and how to joinNCT07815925 - 2. fázisTaking peoplePhase II Trial of RC1416 Injection in Asthma
- Where
- Anqing, Anyang, Beijing, Changchun, Chengdu, Chongqing, Daqing, Hangzhou, Harbin, Heze, Hohhot, Jilin City, Jinan, Jining, Kaifeng, Lanzhou, Mianyang, Nanchang, Nanjing, Ningbo, Qingdao, Qiqihar, Sanmenxia, Shanghai, Shenyang, Shijiazhuang, Suzhou, Tangshan, Wenzhou, Xi'an, Xingtai, Xinxiang, Xuzhou, Yantai, Yichang, Yinchuan, Yuncheng, Zhangjiakou, Zibo
- Életkor
- 18 év to 75 év
- People
- 195
- Run by
- Nanjing RegeneCore Biotech Co., Ltd.
See details and how to joinNCT07403487 - 1. fázisTaking peopleA Randomized, Phase Ib, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SKB575 (HBM7575) in Participants With Asthma
- Where
- Chengdu
- Életkor
- 18 év to 70 év
- People
- 36
- Run by
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
See details and how to joinNCT07732023 - 3. fázisTaking peopleTQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
- Where
- Anyang, Baotou, Beijing, Bozhou, Cangzhou, Changchun, Changsha, Chengdu, Chifeng, Dalian, Daqing, Enshi, Foshan, Gansu, Guangzhou, Guilin, Guiyang, Haikou, Harbin, Hefei, Heze, Hohhot, Huizhou, Jiaozuo, Jinan, Jincheng, Jinhua, Jining, Kunming, Lanzhou, Loudi, Lu'an, Luoyang, Nanchang, Nanjing, Ningbo, Panjin, Pingxiang, Qingdao, Qiqihar, Shanghai, Shenyang, Shihezi, Suining, Tai’an, Taiyuan, Taizhou, Tianjin, Tongling, Ürümqi, Weifang, Wenzhou, Wuhan, Wuxi, Xiamen, Xi'an, Xi’an, Xianyang, Xingtai, Xinxiang, Xuzhou, Yangquan, Yangzhou, Yantai, Yibin, Yinchuan, Yuyao, Zaozhuang, Zhangzhou, Zhengzhou, Zhenjiang, Zhongshan, Zhoukou, Zibo
- Életkor
- 18 év to 75 év
- People
- 660
- Run by
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
See details and how to joinNCT06829784 - No phaseTaking peopleA Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
- Where
- Beijing, Changsha, Chengdu, Dongguan, Foshan, Guangzhou, Hainan, Hohhot, Huizhou, Kunming, Nanjing, Nanning, Shanghai, Shenyang, Taiyuan, Wenzhou, Wuhan, Xi'an, Xuzhou, Zhanjiang, Zhaoqing
- Életkor
- 18 év to 75 év
- People
- 355
- Run by
- AstraZeneca
See details and how to joinNCT06419413 - 3. fázisTaking peopleBeclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 416
- Run by
- Lunan Better Pharmaceutical Co., LTD.
See details and how to joinNCT07768891 - No phaseNot yet taking people in KínaReal-World Effectiveness of Tezepelumab in Allergic Bronchopulmonary Aspergillosis
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Qianfoshan Hospital
See details and how to joinNCT07757841 - 1/2. fázisTaking peopleA Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Jinan, Nanjing, Qingdao, Shanghai, Wenzhou, Yantai, Zibo
- Életkor
- 18 év to 75 év
- People
- 64
- Run by
- Bambusa Therapeutics
See details and how to joinNCT07436949 - 3. fázisTaking peopleEfficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 554
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07546981